By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company MiniMed Group, Inc. Common Stock

MiniMed Group, Inc. Common Stock (MMED)

NASDAQ Market Data in USD
$371.00
+$1.61
+0.44%
Last Update: 18 Jul 2026, 03:22
$0.00
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
$270.53-$502.81
52 Week Range

MMED Stock Price Chart

Explore MiniMed Group, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze MMED price movements and trends.

MMED Company Profile

Discover essential business fundamentals and corporate details for MiniMed Group, Inc. Common Stock (MMED) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

5 Mar 2026

Employees

CEO

Que Thanh Dallara

Description

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

MMED Financial Timeline

Browse a chronological timeline of MiniMed Group, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 30 Sept 2026

EPS estimate is $0.11, while revenue estimate is $828.52m.

Upcoming earnings on 17 Aug 2026

EPS estimate is $0.10, while revenue estimate is $827.70m.

Earnings released on 3 Jun 2026

EPS came in at -$0.68 falling short of the estimated -$0.15 by -356.16%, while revenue for the quarter reached $837.00m , beating expectations by +1.01%.

Earnings released on 17 Apr 2026

EPS came in at -$0.10 falling short of the estimated $0.17 by -155.82%, while revenue for the quarter reached $790.00m , beating expectations by +0.07%.

MMED Stock Performance

Access detailed MMED performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run